Finance

Lister
Utsikter: 38.2 % optimistiske·8.8 % pessimistiske
GÃ¥ til analysen
DKNG:NASDAQ
DraftKings Inc
19,58 USD
−1,46%
(−0,29) 1 D
19,59 USD
+0,07% (+0,014)
Etter stengetid
Stengt: 9. okt., 16:00:01 GMT-4  ·   USD
Alle symboler
SymbolPrisEndringEndring (%)
Genererer viktig statistikk for DKNG …
Ã…pne
19,87 USD
Høy
20,09 USD
Lav
19,22 USD
Markedsverdi
9,72 mrd.
Snittvolum
14,03 mill.
Volum
9,60 mill.
52 u høy
36,98 USD
52 u lav
18,52 USD
EPS
−0,34 USD
Beta
1,61
Utestående aksjer
496,45 mill.
Antall ansatte
6k
Ã…pne
19,87 USD
Høy
20,09 USD
Lav
19,22 USD
Markedsverdi
9,72 mrd.
Snittvolum
14,03 mill.
Volum
9,60 mill.
52 u høy
36,98 USD
52 u lav
18,52 USD
EPS
−0,34 USD
Beta
1,61
Utestående aksjer
496,45 mill.
Antall ansatte
6k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Profil
DraftKings Inc. is an American digital sports entertainment gambling company based in Boston, Massachusetts. It offers sportsbook and daily fantasy sports services. The company was originally launched in 2012 as a DFS provider, competing principally with the New York–based FanDuel. In May 2018, amid the widening legalization of sports betting in the United States, DraftKings began to expand into online and retail sportsbooks to leverage its brand awareness and customer base. DraftKings became a publicly traded company through a reverse merger with SBTech, a Bulgarian technology company, and special-purpose acquisition company Diamond Eagle Acquisition Corp in April 2020. Draft Kings is known as one of the biggest sportsbooks and holds a big portion of the market share in the economy. Draft Kings is legal in 26 states, as of December 2025. In July 2026, Draft Kings filed a lawsuit to halt the city of Philadeliphia's investigation into its sportsbook and online casino. Wikipedia
Om DraftKings Inc
Administrerende direktørJason Robins
Ansatte5,5k
Grunnlagt2012
HovedkontorBoston, Massachusetts, USA
Sektor-
Analytikervurderinger
Basert på 24 analytikere som har gitt aksjevurderinger for DKNG de siste 3 månedene
Sterkt kjøp
Kjøp
23
Vent
1
Selg
0
12-månedersprognose
Basert på 24 Wall Street-analytikere som har gitt 12-måneders prismål for DKNG de siste 3 månedene.
Høyest
Gjeldende 19,58 USD
48,00 USD (+145,15%)
Gjennomsnittlig
33,29 USD (+70,02%)
Lavest
27,00 USD (+37,90%)
Analytiker
Anbefaling
Handling
Prismål
Anslått
Dato
Brandt Montour
Barclays
Buy
Maintained
34,00 USD
+73,6%
10/09/2026
Joseph Stauff
Susquehanna
Buy
Maintained
27,00 USD
+37,9%
10/08/2026
Curry Baker
Guggenheim
Buy
Reiterated
30,00 USD
+53,2%
10/07/2026
Shaun Kelley
Bank of America Securities
Buy
Upgraded
27,00 USD
+37,9%
10/05/2026
Lance Vitanza
TD Cowen
Buy
Maintained
35,00 USD
+78,8%
09/30/2026
Jed Kelly
Oppenheimer
Buy
Maintained
35,00 USD
+78,8%
09/25/2026
Mike Hickey
StoneX
Buy
Maintained
30,00 USD
+53,2%
09/24/2026
Trey Bowers
Wells Fargo
Buy
Maintained
29,00 USD
+48,1%
09/23/2026
Jordan Bender
Citizens JMP
Buy
Maintained
35,00 USD
+78,8%
09/24/2026
Greg Gibas
Northland Securities
Hold
Maintained
28,00 USD
+43%
09/22/2026
Robin M. Farley
UBS
Buy
Maintained
48,00 USD
+145,1%
09/18/2026
Bernie McTernan
Needham
Buy
Maintained
35,00 USD
+78,8%
09/18/2026
James Hardiman
Citi
Buy
Maintained
32,00 USD
+63,4%
09/11/2026
David Katz
Jefferies
Buy
Maintained
44,00 USD
+124,7%
09/03/2026
Peter Supino
Wolfe Research
Buy
Initiated
40,00 USD
+104,3%
09/02/2026
Ian S. Moore
Bernstein
Buy
Maintained
29,00 USD
+48,1%
09/02/2026
John DeCree
CBRE
Buy
Maintained
27,00 USD
+37,9%
08/21/2026
Stephen Grambling
Morgan Stanley
Buy
Reiterated
36,00 USD
+83,9%
08/12/2026
Unknown Analyst
Berenberg Bank
Buy
Maintained
27,50 USD
+40,4%
08/11/2026
Jeffrey Stantial
Stifel Nicolaus
Buy
Maintained
36,00 USD
+83,9%
08/11/2026
Daniel Politzer
J.P. Morgan
Buy
Maintained
33,00 USD
+68,5%
08/10/2026
Barry Jonas
Truist Financial
Buy
Maintained
29,00 USD
+48,1%
08/10/2026
Matthew Weber
Canaccord Genuity
Buy
Maintained
44,00 USD
+124,7%
08/07/2026
Nick McKay
Freedom Capital Markets
Buy
Maintained
28,50 USD
+45,6%
07/20/2026
Steven Pizzella
Deutsche Bank
Hold
Reiterated
28,00 USD
+43%
07/09/2026
Clark Lampen
BTIG
Buy
Reiterated
30,00 USD
+53,2%
07/06/2026
Ryan Sigdahl
Craig-Hallum
Buy
Maintained
-
-
06/26/2026
Unknown Analyst
Exane BNP Paribas
Sell
Downgraded
-
-
05/14/2026
Benjamin Chaiken
Mizuho Securities
Buy
Maintained
45,00 USD
+129,8%
05/12/2026
Brian Pitz
BMO Capital
Buy
Reiterated
50,00 USD
+155,4%
05/08/2026
Michael Graham
Canaccord Genuity
Buy
Maintained
44,00 USD
+124,7%
05/08/2026
Arpine Kocharyan
UBS
Buy
Maintained
43,00 USD
+119,6%
05/08/2026
Robert Fishman
MoffettNathanson
Hold
Downgraded
-
-
04/24/2026
Eric Sheridan
Goldman Sachs
Buy
Maintained
31,00 USD
+58,3%
03/24/2026
John Staszak
Argus Research
Hold
Downgraded
-
-
03/17/2026
Jason Tilchen
Canaccord Genuity
Buy
Maintained
44,00 USD
+124,7%
03/03/2026
Jack Cummings
Berenberg Bank
Buy
Maintained
26,40 USD
+34,8%
02/23/2026
David Bain
Texas Capital Securities
Hold
Maintained
27,00 USD
+37,9%
02/18/2026
Chad Beynon
Macquarie
Buy
Maintained
40,00 USD
+104,3%
02/17/2026
Andrew Tam CFA
Rothschild & Co Redburn
Hold
Maintained
35,00 USD
+78,8%
01/30/2026
Siste rapport
7. aug. 2026
Regnskapsperiode
kvartal2 2026
0,09 USD / 0,19 USD
−53,06%sto ikke til forventningene
Omsetning/anslag (USD)
1,44 mrd. / 1,51 mrd.
−4,48%sto ikke til forventningene
Resultatpresentasjon for K2 2026.
Venter på resultatpresentasjonen
Kort fortalt
Statistikk fra de siste nyhetene og rapportene
Tidligere rapporterAlle verdier i USD
Loading Previous Earnings...
Inntekt
Nettoinntekt
Alle verdier i USD
sep. 2025
des. 2025
mars 2026
juni 2026
Inntekt
1,14 mrd.
1,99 mrd.
1,65 mrd.
1,44 mrd.
Varekostnad
328,63 mill.
404,70 mill.
379,85 mill.
372,14 mill.
Direkte driftskostnader
328,63 mill.
404,70 mill.
379,85 mill.
372,14 mill.
Utgifter til forskning og utvikling
114,68 mill.
133,56 mill.
123,18 mill.
127,65 mill.
Totale kostnader til forskning og utvikling
-
-
-
-
Salgskostnader, generelle kostnader og administrative kostnader
517,15 mill.
616,16 mill.
567,67 mill.
491,98 mill.
Driftskostnader
1,09 mrd.
1,42 mrd.
1,26 mrd.
1,14 mrd.
Totale driftskostnader
1,42 mrd.
1,82 mrd.
1,64 mrd.
1,51 mrd.
Driftsinntekter
−271,89 mill.
164,97 mill.
5,85 mill.
−68,17 mill.
Andre ikke-operasjonelle inntekter
4,23 mill.
3,84 mill.
-
3,75 mill.
EBT inkludert uvanlige elementer
−268,85 mill.
146,58 mill.
27,44 mill.
−69,41 mill.
EBT uten uvanlige elementer
−285,57 mill.
162,94 mill.
4,62 mill.
−69,41 mill.
Kostnad for inntektsskatt
−12,06 mill.
10,15 mill.
6,37 mill.
−1,80 mill.
Faktisk avgiftssats
4,49 %
6,92 %
23,21 %
2,59 %
Andre driftskostnader
455,45 mill.
669,81 mill.
569,53 mill.
519,65 mill.
Nettoinntekt
−256,79 mill.
136,43 mill.
21,07 mill.
−67,61 mill.
Netto fortjenestemargin
−22,45 %
6,86 %
1,28 %
−4,68 %
Resultat per aksje
−0,26
0,36
0,20
0,09
Rente- og investeringsinntekter
-
-
-
-
Rentekostnader
−19,57 mill.
−5,43 mill.
−5,74 mill.
−7,43 mill.
Netto rentekostnader
−19,57 mill.
−5,43 mill.
−5,74 mill.
−7,43 mill.
Avskrivnings- og amortiseringskostnader
-
-
-
-
EBITDA
−205,82 mill.
238,98 mill.
77,51 mill.
12,17 mill.
Gevinst eller tap ved salg av eiendeler
-
-
-
-
Transaksjoner gjort av nøkkelpersoner
Data om transaksjoner gjort av nøkkelpersoner hentes fra tredjepartskilder. Finn ut mer
Nøkkelperson
Stilling
Type
Dato
Aksjer
Beløp
Side 1
AI-innhold kan inneholde feil. Finn ut mer
Google-apper